HTLV-1 in rural Guinea-Bissau: Prevalence, incidence and a continued association with HIV between 1990 and 2007

Retrovirology

Volumn 7, Issue , 2010, Pages

  van Tienen, Carla ^a   van der Loeff, Maarten F S ^b   Peterson, Ingrid ^a   Cotten, Matthew ^a   Holmgren, Birgitta ^c   Andersson, Sören ^d   Vincent, Tim ^a   Sarge Njie, Ramu ^a   Rowland Jones, Sarah ^e   Jaye, Assan ^a   Aaby, Peter ^f   Whittle, Hilton ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c LUND UNIVERSITY   (Sweden)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^f Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (Guinea-Bissau)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CHILD; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; GUINEA-BISSAU; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; RURAL POPULATION; SEX DIFFERENCE; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; ADOLESCENT; AGED; COMORBIDITY; CROSS-SECTIONAL STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; ISOLATION AND PURIFICATION; MIDDLE AGED; RISK FACTOR; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN T-LYMPHOTROPIC VIRUS 1;

ADOLESCENT; ADULT; AGE FACTORS; AGED; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GUINEA-BISSAU; HIV INFECTIONS; HIV-1; HIV-2; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 77954383008     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-50     Document Type: Article

References (54)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980, 77:7415-7419. 10.1073/pnas.77.12.7415, 350514, 6261256.
2. Van Dooren S, Salemi M, Vandamme AM. Dating the origin of the African human T-cell lymphotropic virus type-i (HTLV-I) subtypes. Mol Biol Evol 2001, 18:661-671.
3. Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 2007, 7:266-281. 10.1016/S1473-3099(07)70081-6, 17376384.
4. Sagawa K, Mochizuki M, Masuoka K, Katagiri K, Katayama T, Maeda T, Tanimoto A, Sugita S, Watanabe T, Itoh K. Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production. J Clin Invest 1995, 95:852-858. 10.1172/JCI117735, 295569, 7860769.
5. LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 1990, 336:1345-1347. 10.1016/0140-6736(90)92896-P, 1978165.
6. Marinho J, Galvao-Castro B, Rodrigues LC, Barreto ML. Increased risk of tuberculosis with human T-lymphotropic virus-1 infection: a case-control study. J Acquir Immune Defic Syndr 2005, 40:625-628. 10.1097/01.qai.0000174252.73516.7a, 16284541.
7. Verdonck K, Gonzalez E, Henostroza G, Nabeta P, Llanos F, Cornejo H, Vanham G, Seas C, Gotuzzo E. HTLV-1 infection is frequent among out-patients with pulmonary tuberculosis in northern Lima, Peru. Int J Tuberc Lung Dis 2007, 11:1066-1072.
8. Arisawa K, Soda M, Akahoshi M, Matsuo T, Nakashima E, Tomonaga M, Saito H. Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atomic-bomb survivors. Jpn J Cancer Res 1998, 89:797-805.
9. Iwata K, Ito S, Saito H, Ito M, Nagatomo M, Yamasaki T, Yoshida S, Suto H, Tajima K. Mortality among inhabitants of an HTLV-I endemic area in Japan. Jpn J Cancer Res 1994, 85:231-237.
10. Melbye M, Poulsen AG, Gallo D, Pedersen JB, Biggar RJ, Larsen O, Dias F, Aaby P. HTLV-1 infection in a population-based cohort of older persons in Guinea-Bissau, West Africa: risk factors and impact on survival. Int J Cancer 1998, 76:293-298. 10.1002/(SICI)1097-0215(19980504)76:3<293::AID-IJC1>3.0.CO;2-Q, 9579561.
11. Holmgren B, da Silva Z, Vastrup P, Larsen O, Andersson S, Ravn H, Aaby P. Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau. Retrovirology 2007, 4:85. 10.1186/1742-4690-4-85, 2222662, 18042276.
12. Schim van der Loeff MF, Holmgren B, Vincent T, Ariyoshi K, Andersson S, Dias F, Aaby P, Whittle H. Survival of HIV-2, HTLV-I or dually infected subjects ina rural area of West Africa: a community-based study with 12 years of follow-up. Abstract 278 of the 2nd IAS (International AIDS Society) on HIV Pathogenesis and Treatment. Paris, France. Antivir Ther 2003, 8(Suppl 1):S187-557. 2003.
13. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005, 24:6058-6068. 10.1038/sj.onc.1208968, 16155612.
14. Brites C, Sampalo J, Oliveira A. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression. AIDS Rev 2009, 11:8-16.
15. Ariyoshi K, Berry N, Cham F, Jaffar S, Schim van der Loeff M, Jobe O, N'Gom PT, Larsen O, Andersson S, Aaby P, Whittle H. Quantification of Human T-lymphotropic virus type I (HTLV-I) provirus load in a rural West African population: no enhancement of human immunodeficiency virus type 2 pathogenesis, but HTLV-I provirus load relates to mortality. J Infect Dis 2003, 188:1648-1651. 10.1086/379780, 14639534.
16. da Silva ZJ, Nielsen J, Andersen A, Oliveira I, Dias F, Rodrigues A, Holmgren B, Andersson S, Aaby P. Decline in human T-cell lymphotropic virus-1 prevalence in urban areas of Bissau, Guinea-Bissau: exploring the association with HIV infections. AIDS 2009,
17. Tortevoye P, Tuppin P, Carles G, Peneau C, Gessain A. Comparative trends of seroprevalence and seroincidence rates of human T cell lymphotropic virus type I and human immunodeficiency virus 1 in pregnant women of various ethnic groups sharing the same environment in French Guiana. Am J Trop Med Hyg 2005, 73:560-565.
18. Djomand G, Greenberg AE, Sassan-Morokro M, Tossou O, Diallo MO, Ekpini E, Ghys P, Soro B, Brattegaard K, Yapi A, et al. The epidemic of HIV/AIDS in Abidjan, Cote d'Ivoire: a review of data collected by Projet RETRO-CI from 1987 to 1993. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 10:358-365.
19. Larsen O, da Silva Z, Sandstrom A, Andersen PK, Andersson S, Poulsen AG, Melbye M, Dias F, Naucler A, Aaby P. Declining HIV-2 prevalence and incidence among men in a community study from Guinea-Bissau. AIDS 1998, 12:1707-1714. 10.1097/00002030-199813000-00020, 9764792.
20. Norrgren H, Andersson S, Biague AJ, da Silva ZJ, Dias F, Naucler A, Biberfeld G. Trends and interaction of HIV-1 and HIV-2 in Guinea-Bissau, west Africa: no protection of HIV-2 against HIV-1 infection. Aids 1999, 13:701-707. 10.1097/00002030-199904160-00011, 10397565.
21. Schim van der Loeff MF, Awasana AA, Sarge-Njie R, van der Sande M, Jaye A, Sabally S, Corrah T, McConkey SJ, Whittle HC. Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2. Int J Epidemiol 2006, 35:1322-1328. 10.1093/ije/dyl037, 16543363.
22. Mansson F, Alves A, Silva ZJ, Dias F, Andersson S, Biberfeld G, Fenyo EM, Norrgren H. Trends of HIV-1 and HIV-2 prevalence among pregnant women in Guinea-Bissau, West Africa: possible effect of the civil war 1998 1999. Sex Transm Infect 2007, 83:463-467. 10.1136/sti.2007.025353, 17611233.
23. da Silva ZJ, Oliveira I, Andersen A, Dias F, Rodrigues A, Holmgren B, Andersson S, Aaby P. Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing?. Aids 2008, 22:1195-1202. 10.1097/QAD.0b013e328300a33d, 18525265.
24. Mansson F, Biague A, da Silva ZJ, Dias F, Nilsson LA, Andersson S, Fenyo EM, Norrgren H. Prevalence and incidence of HIV-1 and HIV-2 before, during and after a civil war in an occupational cohort in Guinea-Bissau, West Africa. AIDS 2009, 23:1575-1582. 10.1097/QAD.0b013e32832cedfb, 19521234.
25. Holmgren B, Andersson S, Harding E, Schim van der Loeff M, Vastrup P, Aaby P, Ariyoshi K, Whittle H. Increased prevalence of HTLV-1 among HIV-2-infected women but not HIV-2-infected men in rural Guinea-Bissau. J Acquir Immune Defic Syndr 2002, 30:342-350.
26. van Tienen C, Schim van der Loeff MF, Zaman SM, Vincent T, Sarge-Njie R, Peterson I, Leligdowicz A, Jaye A, Rowland-Jones S, Aaby P, Whittle H. Two distinct epidemics: the rise of HIV-1 and decline of HIV-2 infection between 1990 and 2007 in rural Guinea-Bissau. J Acquir Immune Defic Syndr 2009, 2009: epub date.
27. Wilkins A, Ricard D, Todd J, Whittle H, Dias F, Paulo Da Silva A. The epidemiology of HIV infection in a rural area of Guinea-Bissau. Aids 1993, 7:1119-1122. 10.1097/00002030-199308000-00015, 8397950.
28. Aaby P, Ariyoshi K, Buckner M, Jensen H, Berry N, Wilkins A, Richard D, Larsen O, Dias F, Melbye M, Whittle H. Age of wife as a major determinant of male-to-female transmission of HIV-2 infection: a community study from rural West Africa. Aids 1996, 10:1585-1590.
29. Le Hesran JY, Delaporte E, Gaudebout C, Trebuck A, Schrijvers D, Josse R, Peeters M, Cheringou H, Dupont A, Larouze B. Demographic factors associated with HTLV-1 infection in a Gabonese community. Int J Epidemiol 1994, 23:812-817. 10.1093/ije/23.4.812, 8002196.
30. Norrgren HR, Bamba S, Larsen O, Da Silva Z, Aaby P, Koivula T, Andersson S. Increased prevalence of HTLV-1 in patients with pulmonary tuberculosis coinfected with HIV, but not in HIV-negative patients with tuberculosis. J Acquir Immune Defic Syndr 2008, 48:607-610. 10.1097/QAI.0b013e31817efb83, 18645510.
31. Cooper S, Schim van der Loeff M, McConkey S, Cooper M, Sarge-Njie R, Kaye S, Whittle H. Neurological morbidity among human T-lymphotropic-virus-type-1-infected individuals in a rural West African population. J Neurol Neurosurg Psychiatry 2009, 80:66-68. 10.1136/jnnp.2008.152819, 18977823.
32. Lemey P, Pybus OG, Wang B, Saksena NK, Salemi M, Vandamme AM. Tracing the origin and history of the HIV-2 epidemic. Proc Natl Acad Sci USA 2003, 100:6588-6592. 10.1073/pnas.0936469100, 164491, 12743376.
33. Poulsen AG, Aaby P, Jensen H, Dias F. Risk factors for HIV-2 seropositivity among older people in Guinea-Bissau. A search for the early history of HIV-2 infection. Scand J Infect Dis 2000, 32:169-175. 10.1080/003655400750045286, 10826903.
34. Pepin J, Plamondon M, Alves AC, Beaudet M, Labbe AC. Parenteral transmission during excision and treatment of tuberculosis and trypanosomiasis may be responsible for the HIV-2 epidemic in Guinea-Bissau. AIDS 2006, 20:1303-1311. 10.1097/01.aids.0000232239.05545.33, 16816560.
35. Jensen ML, Dave S, Schim van der Loeff M, da Costa C, Vincent T, Leligdowicz A, Benn CS, Roth A, Ravn H, Lisse IM, Whittle H, Aaby P. Vaccinia scars associated with improved survival among adults in rural Guinea-Bissau. PLoS ONE 2006, 1:e101. 10.1371/journal.pone.0000101, 1762358, 17183634.
36. Plamondon M, Labbe AC, Frost E, Deslandes S, Alves AC, Bastien N, Pepin J. Hepatitis C virus infection in Guinea-bissau: a sexually transmitted genotype 2 with parenteral amplification?. PLoS ONE 2007, 2:e372. 10.1371/journal.pone.0000372, 1847532, 17440608.
37. Kaplan JE, Khabbaz RF, Murphy EL, Hermansen S, Roberts C, Lal R, Heneine W, Wright D, Matijas L, Thomson R, Rudolph D, Switzer WM, Kleinman S, Busch M, Schreiber GB. Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12:193-201.
38. Holmgren B, Aaby P, Jensen H, Larsen O, da Silva Z, Lisse IM. Increased prevalence of retrovirus infections among older women in Africa. Scand J Infect Dis 1999, 31:459-466. 10.1080/00365549950163978, 10576124.
39. Olaleye DO, Omotade OO, Sheng Z, Adeyemo AA, Odaibo GN. Human T-cell lymphotropic virus types I and II infections in mother-child pairs in Nigeria. J Trop Pediatr 1999, 45:66-70. 10.1093/tropej/45.2.66, 10341498.
40. Nyambi PN, Ville Y, Louwagie J, Bedjabaga I, Glowaczower E, Peeters M, Kerouedan D, Dazza M, Larouze B, van der Groen G, Delaporte E. Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I/II) in Gabon: a prospective follow-up of 4 years. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12:187-192.
41. Larsen O, Andersson S, da Silva Z, Hedegaard K, Sandstrom A, Naucler A, Dias F, Melbye M, Aaby P. Prevalences of HTLV-1 infection and associated risk determinants in an urban population in Guinea-Bissau, West Africa. J Acquir Immune Defic Syndr 2000, 25:157-163. 10.1097/00042560-200010010-00010, 11103046.
42. Norrgren H, Andersson S, Naucler A, Dias F, Johansson I, Biberfeld G. HIV-1, HIV-2, HTLV-I/II and Treponema pallidum infections: incidence, prevalence, and HIV-2-associated mortality in an occupational cohort in Guinea-Bissau. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 9:422-428. 10.1097/00042560-199508000-00014, 7600111.
43. Zehender G, Ebranati E, De Maddalena C, Gianelli E, Riva A, Rusconi S, Massetto B, Rankin F, Acurie M, Galli M. Description of a "trans-Saharan" strain of human T-lymphotropic virus type 1 in West Africa. J Acquir Immune Defic Syndr 2008, 47:269-273. 10.1097/QAI.0b013e31816649a4, 18398969.
44. Takezaki T, Tajima K, Komoda H, Imai J. Incidence of human T lymphotropic virus type I seroconversion after age 40 among Japanese residents in an area where the virus is endemic. J Infect Dis 1995, 171:559-565.
45. Figueroa JP, Morris J, Brathwaite A, Ward E, Peruga A, Hayes R, Vermund SH, Blattner W. Risk factors for HTLV-I among heterosexual STD clinic attenders. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 9:81-88.
46. Stuver SO, Tachibana N, Okayama A, Shioiri S, Tsunetoshi Y, Tsuda K, Mueller NE. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J Infect Dis 1993, 167:57-65.
47. Bégaud E, Chartier L, Marechal V, Ipero J, Léal J, Versmisse P, Breton G, Fontanet A, Capoulade-Metay C, Fleury H, Barré-Sinoussi F, Scott-Algara D, Pancino G. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology 2006, 3:35. 10.1186/1742-4690-3-35, 1524799, 16792805.
48. Koning FA, Otto SA, Hazenberg MD, Dekker L, Prins M, Miedema F, Schuitemaker H. Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection. J Immunol 2005, 175:6117-6122.
49. Schim van der Loeff MF, Aaby P, Aryioshi K, Vincent T, Awasana AA, Da Costa C, Pembrey L, Dias F, Harding E, Weiss HA, Whittle HC. HIV-2 does not protect against HIV-1 infection in a rural community in Guinea-Bissau. Aids 2001, 15:2303-2310. 10.1097/00002030-200111230-00012, 11698704.
50. Ricard D, Wilkins A, N'Gum PT, Hayes R, Morgan G, Da Silva AP, Whittle H. The effects of HIV-2 infection in a rural area of Guinea-Bissau. AIDS 1994, 8:977-982. 10.1097/00002030-199407000-00016, 7946109.
51. Ariyoshi K, Berry N, Wilkins A, Ricard D, Aaby P, Nauclér A, Ngom PT, Jobe O, Jaffar S, Dias F, Tedder RS, Whittle H. A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa. J Infect Dis 1996, 173:245-248.
52. Leligdowicz A, Yindom LM, Onyango C, Sarge-Njie R, Alabi A, Cotten M, Vincent T, da Costa C, Aaby P, Jaye A, Dong T, McMichael A, Whittle H, Rowland-Jones S. Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. J Clin Invest 2007, 117:3067-3074. 10.1172/JCI32380, 1964515, 17823657.
53. Krook A, Albert J, Andersson S, Biberfeld G, Blomberg J, Eklund I, Engström A, Julander I, Käll K, Martin C, Stendahl P, Struve J, Sönnerborg A. Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 15:381-386.
54. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 2007, 4:e296. 10.1371/journal.pmed.0040296, 2020495,2020495, 17941714.